New App Alert! Mole Mapper to Provide Big Data on Melanoma in Real Time
Mole Mapper gives individuals the opportunity to contribute to a melanoma research initiative. Encourage your patients to download it today!
Tag: melanoma
All
PopularAll
Latest
Antibiotics May Help to Treat Melanoma
Researchers from KU Leuven may have found a new weapon in the fight against melanoma: antibiotics that target the "power plants" of cancer cells. Their findings are published in the Journal of Experimental Medicine.
All
Latest
Rising Demand for Menopause Makeovers: Reversing Facial Aging
With millions of women experiencing menopause, the decline in estrogen affects skin and bone health, leading many to seek surgical and non-surgical facial rejuvenation treatments to address the aging effects of this life stage.
UV Exposure and Melanoma Risk in Patients With Skin of Color
People of color are generally diagnosed with melanoma at more advanced stages and have lower 5-year survival rates and worse outcomes compared with White patients, according to Dermatology Advisor.
Read More
Vaccine Produces Long-Lasting Anti-Tumor Response in Patients with Melanoma
Patients treated with a vaccine tailored to mutated proteins on patients’ own tumor cells, continue to have a strong immune response to the cancer four years after being vaccinated. Results demonstrate the ability of personalized cancer vaccines to provide long-term immunity against some cancers.
Read More
How COVID-19 Caused Delays in Skin Cancer Diagnosis
When caught early, skin cancer, including melanoma is highly treatable. However, from March to May 2020 during the peak of the first wave of COVID-19, the pandemic closed many dermatology offices across the country — limiting patients’ access to the timely diagnosis and management of skin cancer.
Read More
UV Exposure Likely Not a Melanoma Risk for People of Color
NEW YORK (Reuters Health) – The association between ultraviolet (UV) exposure and melanoma is “weak” for skin of color, according to a new systematic review.
Read More
Boost the Melanoma Recurrence Prevention Vaccine This Way
A vaccine created to prevent the recurrence of melanoma is about twice as effective when patients also receive two components that boost the number and effectiveness of immune system cells called dendritic cells, according to phase 2 clinical trial results published recently in Nature Cancer.
Read More
Racial Disparities in Melanoma-Specific Survival Persist
Racial disparities persist in the outcomes of patients with cutaneous melanoma, according to the results of a large surveillance study published in the Journal of the American Academy of Dermatology, per Dermatology Advisor.
Read More
Pale Melanomas Masked By Albino Gene
People with pale-colored melanomas are more likely to have a gene mutation associated with albinism, University of Queensland researchers suggest, in PLOS One.
Read More
Predicting Melanoma in Small- and Medium-Sized Congenital Nevi
In patients with small- or medium-sized congenital nevi, peripheral location of the suspicious area and negative network may be the strongest dermatoscopic predictors of melanoma, researchers reported in a study published in the Journal of the American Academy of Dermatology, per Dermatology Advisor.
Read More
Researchers Outline Need for Evaluation of Gene Expression Profiling in Melanoma
In a consensus statement, researchers caution against routine use of currently available genetic expression profile tests for patients with cutaneous melanoma, per Medical Xpress.
Read More
UV, Sex, and Age Contribute to Melanoma Tumor Evolution
Although ultraviolet (UV) radiation damage and clock-like mutations associated with cell division contribute to melanoma risk, sex, and age may represent the final mutational composition of skin cancer, according to study research published in the British Journal of Dermatology, Dermatology Advisor reports.
Read More
Survey: 60% of Americans Say They Have Gotten So Badly Sunburned Their Clothes Were Uncomfortable
Dermatologists urge Americans to #PracticeSafeSun to reduce their risk of skin cancer, the most common cancer in the US.
Read More
FDG-PET Superior to CT for Predicting Melanoma Relapse After Immunotherapy
Most patients with a partial response (PR) on a computed tomography (CT) scan and a complete metabolic response (CMR) on a fluorodeoxyglucose (FDG)-positron emission tomography (PET) scan should be considered to have achieved complete response and at low risk for relapse of melanoma, according to research, per Dermatology Advisor.
Read More
Black Patients Face Longer Delays in Time to Surgery for Melanoma
Black patients with earlier-stage melanoma were more likely than their non-Hispanic white counterparts to experience delayed time from diagnosis to definitive surgery, according to a study, per Healio.
Read More
Antihistamines May Help Patients with Malignant Melanoma
A common allergy medicine may help improve survival among patients suffering from malignant melanoma, according to a new study from Lund University in Sweden.
Read More
Lymph Node Status Predicts Survival in Patients with Vulvar, Vaginal Melanoma
Lymph node status is a predictor of survival in patients with vulvar melanoma and vaginal melanoma, according to a study published in American Journal of Clinical Dermatology, Healio reports.
Read More